Predictive markers and driving factors behind Richter syndrome development

References

• Richter MN. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukaemia. Am. J. Pathol.4(4), 285–292 (1928).
   PubMedGoogle Scholar
• Hallek M, Cheson BD, Catovsky D et al. International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute Working Group 1996 guidelines. Blood111(12), 5446–5456 (2008).
   PubMed Web of Science ®Google Scholar
• Rossi D, Cerri M, Capello D, Deambrogi C et al. Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br. J. Haematol.142(2), 202–215 (2008).
   PubMed Web of Science ®Google Scholar
• Tsimberidou A-M, Keating MJ. Richter syndrome. Biology, incidence, and therapeutic strategies. Cancer103(2), 216–228 (2005).
   PubMed Web of Science ®Google Scholar
• Maddocks-Christianson K, Slager SL, Zent CS et al. Risk factors for development of a second malignancy in patients with chronic lymphocytic leukaemia. Br. J. Haematol.139(3), 398–404 (2007).
   PubMed Web of Science ®Google Scholar
• Cherepakhin V, Baird SM, Meisenholder GW, Kipps TJ. Common clonal origin of chronic lymphocytic leukemia and high grade lymphoma of Richter’s syndrome. Blood82(10), 3141–3147 (1993).
   PubMed Web of Science ®Google Scholar
• Matolcsy A, Inghirami G, Knowles DM. Molecular genetic demonstration of the diverse evolution of Richter’s syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood83(5), 1363–1372 (1994).
   PubMed Web of Science ®Google Scholar
• Nakamura N, Kuze T, Hashimoto Y et al. Analysis of the immunoglobulin heavy chain gene of secondary diffuse large B-cell lymphoma that subsequently developed in four cases with B-cell chronic lymphocytic leukemia or lymphoplasmacytoid lymphoma (Richter syndrome). Pathol. Int.50(8), 636–643 (2000).
   PubMed Web of Science ®Google Scholar
• Timár B, Fülöp Z, Csernus B et al. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter’s syndrome. Leukemia18(2), 326–330 (2004).
   PubMed Web of Science ®Google Scholar
• Smit LA, van Maldegem F, Langerak AW et al. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter’s transformation. Haematologica91(7), 903–911 (2006).
   PubMedGoogle Scholar
• Mao Z, Quintanilla-Martinez L, Raffeld M et al. IgVH mutational status and clonality analysis of Richter’s transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am. J. Surg. Pathol.31(10), 1605–1614 (2007).
   PubMed Web of Science ®Google Scholar
• O’Brien SM, Kantarjian HM, Thomas DA et al. Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia. Cancer98(12), 2657–2663 (2003).
   PubMed Web of Science ®Google Scholar
• Janssens A, Berth M, De Paepe P et al. EBV negative Richter’s syndrome from a coexistent clone after salvage treatment with alemtuzumab in a CLL patient. Am. J. Hematol.81(9), 706–712 (2006).
   PubMedGoogle Scholar
• Rossi D, Berra E, Cerri M et al. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. Haematologica91(10), 1405–1409 (2006).
   PubMedGoogle Scholar
• Montoto S, Davies AJ, Matthews J et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J. Clin. Oncol.25(17), 2426–2433 (2007).
   PubMed Web of Science ®Google Scholar
• Armitage JO, Dick FR, Corder MP. Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. Cancer41(2), 422–427 (1978).
   PubMed Web of Science ®Google Scholar
• Ott MM, Ott G, Roblick U et al. Localized gastric non-Hodgkin’s lymphoma of high-grade malignancy in patients with pre-existing chronic lymphocytic leukemia or immunocytoma. Leukemia9(4), 609–614 (1995).
   PubMed Web of Science ®Google Scholar
• Ratnavel RC, Dunn-Walters DK, Boursier L et al. B-cell lymphoma associated with chronic lymphocytic leukaemia: two cases with contrasting aggressive and indolent behaviour. Br. J. Dermatol.140(4), 708–714 (1999).
   PubMed Web of Science ®Google Scholar
• Parrens M, Sawan B, Dubus P et al. Primary digestive Richter’s syndrome. Mod. Pathol.14(5), 452–457 (2001).
   PubMed Web of Science ®Google Scholar
• Omoti CE, Omoti AE. Richter syndrome: a review of clinical, ocular, neurological and other manifestations. Br. J. Haematol.142(5), 709–716 (2008).
   PubMed Web of Science ®Google Scholar
• Bruzzi JF, Macapinlac H, Tsimberidou AM et al. Detection of Richter’s transformation of chronic lymphocytic leukemia by PET/CT. J. Nucl. Med.47(8), 1267–1273 (2006).
   PubMed Web of Science ®Google Scholar
• Matolcsy A, Chadburn A, Knowles DM. De novo CD5-positive and Richter’s syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am. J. Pathol.147(1), 207–216 (1995).
   PubMed Web of Science ®Google Scholar
• Hans CP, Weisenburger DD, Greiner TC et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood103(1), 275–282 (2004).
   PubMed Web of Science ®Google Scholar
• Tsimberidou A-M, O’Brien S, Khouri I et al. Clinical outcomes and prognostic factors in patients with Richter’s syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. J. Clin. Oncol.24(15), 2343–2351 (2006).
   PubMed Web of Science ®Google Scholar
• Rossi D, Spina V, Deambrogi C et al. The genetics of Richter syndrome identifies disease heterogeneity and is an independent predictor of survival post transformation. Presented at: 15th Congress of the European Hematology Association. Barcelona, Spain, 10–13 June 2010.
   Google Scholar
• Rossi D, Rasi S, Capello D, Gaidano G. Prognostic assessment of BCL2–938C>A polymorphism in chronic lymphocytic leukemia. Blood111(1), 466–468 (2008).
   PubMed Web of Science ®Google Scholar
• Rossi D, Zucchetto A, Rossi FM et al. CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia. Haematologica93(10), 1575–1579 (2008).
   PubMed Web of Science ®Google Scholar
• Rossi D, Spina V, Cerri M et al. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytc leukemia transformation to Richter syndrome. Clin. Cancer Res.15(13), 4415–4422 (2009).
   PubMed Web of Science ®Google Scholar
• Rossi D, Lobetti Bodoni C, Genuardi E et al. Telomere length is an independent predictor of survival, treatment requirement and Richter’s syndrome transformation in chronic lymphocytic leukemia. Leukemia23(6), 1062–1072 (2009).
   PubMed Web of Science ®Google Scholar
• Calin GA, Ferracin M, Cimmino A et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med.353(17), 1793–1801 (2005).
   PubMed Web of Science ®Google Scholar
• Kienle DL, Korz C, Hosch B et al. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes. J. Clin. Oncol.23(16), 3780–3792 (2005).
   PubMed Web of Science ®Google Scholar
• Klein U, Lia M, Crespo M et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell17(1), 28–40 (2010).
   PubMed Web of Science ®Google Scholar
• Starostik P, Patzner J, Greiner A et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood99(1), 3–9 (2002).
   PubMed Web of Science ®Google Scholar
• Deambrogi C, Cresta S, Cerri M et al. 14q32 translocations and risk of Richter’s transformation in chronic lymphocytic leukaemia. Br. J. Haematol.144(1), 131–133 (2009).
   PubMed Web of Science ®Google Scholar
• Stamatopoulos K, Belessi C, Moreno C et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood109(1), 259–270 (2007).
   PubMed Web of Science ®Google Scholar
• Bomben R, Dal Bo M, Capello D et al. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicenter study. Br. J. Haematol.144(4), 492–506 (2009).
   PubMed Web of Science ®Google Scholar
• Sutton LA, Kostareli E, Hadzidimitriou A et al. Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4–34 receptors: implications for ongoing interactions with antigen. Blood114(20), 4460–4468 (2009).
   PubMedGoogle Scholar
• Darzentas N, Hadzidimitriou A, Murray F et al. A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia24(1), 125–132 (2010).
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F, Ghia P. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease? J. Clin. Oncol.26(27), 4497–4503 (2008).
   PubMed Web of Science ®Google Scholar
• Chu CC, Catera R, Zhang L et al. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood115(19), 3907–3915 (2010).
   PubMed Web of Science ®Google Scholar
• Del Poeta G, Maurillo L, Venditti A et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood98(9), 2633–2639 (2001).
   PubMed Web of Science ®Google Scholar
• Ibrahim S, Keating M, Do KA et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood98(1), 181–186 (2001).
   PubMed Web of Science ®Google Scholar
• Jaksic O, Paro MM, Kardum Skelin I, Kusec R, Pejsa V, Jaksic B. CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow. Blood103(5), 1968–1969 (2004).
   PubMed Web of Science ®Google Scholar
• Deaglio S, Vaisitti T, Aydin S et al. CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential. Blood110(12), 4012–4021 (2007).
   PubMed Web of Science ®Google Scholar
• Deaglio S, Capobianco A, Bergui L et al. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood102(6), 2146–2155 (2003).
   PubMed Web of Science ®Google Scholar
• Deaglio S, Vaisitti T, Aydin S, Ferrero E, Malavasi F. In-tandem insights from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. Blood108(4), 1135–1144 (2006).
   PubMed Web of Science ®Google Scholar
• Patten PE, Buggins AG, Richards J et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood111(10), 5173–5181 (2008).
   PubMed Web of Science ®Google Scholar
• Kishimoto H, Hoshino S, Ohori M et al. Molecular mechanisms of human CD38 gene expression by retinoic acid. Identification of retinoic acid response element in the first intron. J. Biol. Chem.273(25), 15429–15434 (1998).
   PubMed Web of Science ®Google Scholar
• Ferrero E, Saccucci F, Malavasi F. The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene. Immunogenetics49(7–8), 597–604 (1999).
   PubMed Web of Science ®Google Scholar
• Aydin S, Rossi D, Bergui L et al.CD38 gene polymorphism and chronic lymphocytic leukemia: a role in Richter syndrome? Blood111(12), 5646–5653 (2008).
   PubMed Web of Science ®Google Scholar
• Rasi S, Spina V, Bruscaggin A et al. A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome. Br. J. Haematol.152(3), 284–294 (2011).
   PubMed Web of Science ®Google Scholar
• Lu D, Zhao Y, Tawatao R et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA101(9), 3118–3123 (2004).
   PubMed Web of Science ®Google Scholar
• Li Y, Pawlik B, Elcioglu N et al. LRP4 mutations alter Wnt/β-catenin signaling and cause limb and kidney malformations in Cenani–Lenz syndrome. Am. J. Hum. Genet.86(5), 696–706 (2010).
   PubMed Web of Science ®Google Scholar
• Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science266(5193), 2011–2015 (1994).
   PubMed Web of Science ®Google Scholar
• Gaidano G, Ballerini P, Gong JZ et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA88(12), 5413–5417 (1991).
   PubMed Web of Science ®Google Scholar
• Lee JN, Giles F, Huh YO et al. Molecular differences between small and large cells in patients with chronic lymphocytic leukemia. Eur. J. Haematol.71(4), 235–242 (2003).
   PubMedGoogle Scholar
• Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RS, Dalla-Favera R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood82(8), 2289–2295 (1993).
   PubMed Web of Science ®Google Scholar
• Lossos IS. Higher-grade transformation of follicular lymphoma – a continuous enigma. Leukemia19(8), 1331–1333 (2005).
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Neumeister P, Goossens T et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature412(6844), 341–346 (2001).
   PubMed Web of Science ®Google Scholar
• Gaidano G, Pasqualucci L, Capello D et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood102(5), 1833–1841 (2003).
   PubMed Web of Science ®Google Scholar
• Libra M, Capello D, Gloghini A et al. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin lymphomas of patients with HCV infection. J. Pathol.206(1), 87–91 (2005).
   PubMedGoogle Scholar
• Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat. Rev. Immunol.8(1), 22–33 (2008).
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Bhagat G, Jankovic M et al. AID is required for germinal center-derived lymphomagenesis. Nat. Genetics40(1), 108–112 (2008).
   PubMed Web of Science ®Google Scholar
• Reiniger L, Bödör C, Bognár Á et al. Richter’s and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Leukemia20(6), 1089–1095 (2006).
   PubMed Web of Science ®Google Scholar
• Han T, Sadamori N, Ozer H et al. Cytogenetic studies in 77 patients with chronic lymphocytic leukemia: correlations with clinical, immunologic, and phenotypic data. J. Clin. Oncol.2(10), 1121–1132 (1984).
   PubMed Web of Science ®Google Scholar
• Hébert J, Jonveaux P, d’Agay MF, Berger R. Cytogenetic studies in patients with Richter’s syndrome. Cancer Genet. Cytogenet.73(1), 65–68 (1994).
   PubMedGoogle Scholar
• Brynes RK, McCourty A, Sun NC, Koo CH. Trisomy 12 in Richter’s transformation of chronic lymphocytic leukemia. Am. J. Clin. Pathol.104(2), 199–203 (1995).
   PubMed Web of Science ®Google Scholar
• Caraway NP, Du Y, Zhang H-Z, Hayes K, Glassman AB, Katz RL. Numeric chromosomal abnormalities in small lymphocytic and transformed large cell lymphomas detected by fluorescence in situ hybridization of fine-needle aspiration biopsies. Cancer90(2), 126–132 (2000).
   PubMedGoogle Scholar
• Santulli B, Kazmierczak B, Napolitano R et al. A 12q13 translocation involving the HMGI-C gene in Richter transformation of a chronic lymphocytic leukemia. Cancer Genet. Cytogenet.119(1), 70–73 (2000).
   PubMed Web of Science ®Google Scholar
• Zenz T, Mertens D, Döhner H, Stilgenbauer S. Molecular diagnostics in chronic lymphocytic leukemia – pathogenetic and clinical implications. Leuk. Lymphoma49(5), 864–873 (2008).
   PubMed Web of Science ®Google Scholar
• Lenz G, Staudt LM. Aggressive lymphomas. N. Engl. J. Med.362(15), 1417–1429 (2010).
   PubMed Web of Science ®Google Scholar
• Beà S, López-Guillermo A, Ribas M et al. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter’s syndrome). Am. J. Pathol.161(3), 957–968 (2002).
   PubMed Web of Science ®Google Scholar
• Scandurra M, Rossi D, Deambrogi C et al. Genomic profiling of Richter’s syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas. Hematol. Oncol.28(2), 62–67 (2010).
   PubMed Web of Science ®Google Scholar
• Cohen Y, Da’as N, Libster D, Amir G, Berrebi A, Polliack A. Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabine-rituximab containing regimens: natural history or related therapy complication. Eur. J. Hematol.68(2), 80–83 (2002).
   PubMed Web of Science ®Google Scholar
• Thornton PD, Bellas C, Santon A et al. Richter’s transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein–Barr virus in its pathogenesis. Leukemia Res.29(4), 389–395 (2005).
   PubMed Web of Science ®Google Scholar